Quantum-enhanced AI fused with a wet-lab data flywheel. Each layer feeds the next; each candidate carries a cryptographically anchored evidence trail. This page is the platform deep dive — the homepage version is the executive summary.
1,200+ pre-validated VH/VL antibody pairs across 80+ therapeutic targets, plus linkers, hinges, and effectors. Validated subset is proprietary; the schema and exemplar entries are public.
Public exemplar subset shown. Full Library access requires Enterprise tier. Backed by GET /v1/library/search.
NOVA-3 assembles candidates across the antibody and binder formats below. These are architectural cartoons of each format's domain layout — chain topology and valency, not folded model outputs. Live, pLDDT-coloured structures appear in the Predict console and the Playground.
IgG · ~150 kDa
Full-length antibody. Bivalent, monospecific; Fc confers half-life and effector function.
Bispecific IgG · asymmetric
Two distinct paratopes on one scaffold (knob-in-hole / charge-pair). Engages two targets at once.
Fab · ~50 kDa
Single antigen-binding fragment — paired VH-CH1 and VL-CL. No Fc, monovalent.
scFv · ~25 kDa
VH and VL on a single chain via a flexible linker. Compact building block for CARs and fusions.
VHH / nanobody · ~15 kDa
Single variable domain from heavy-chain-only antibodies. Smallest format; stable, reaches cryptic epitopes.
Tandem scFv · no Fc
Two scFv strung in series (BiTE-like). Two binding sites, small size; redirects effector cells.
Schematics, not outputs. Domain blocks are coloured by chain class — heavy copper, light verdigris, paratope sodium, second specificity magenta. Folded structures are coloured separately by pLDDT confidence.
CVaR-VQE on IBM Heron r3 (ibm_boston · 156Q) for active-space corrections (production deployment Q3 '26); QAOA on Quantinuum Helios (98Q, all-to-all connectivity) for assignment problems; quantum Bayesian optimization on simulator. Every job's cost, calibration snapshot, and result is logged. Hardware fraction reported transparently. No claim of demonstrated quantum advantage in ground-state chemistry (cf. Lee et al., Nat Commun 2023); we engage with the open question.
Next.js 15 + tRPC + Mol*. Same FastAPI backend the Streamlit fallback uses. Behind Cloudflare Access; role-based ACL for engineering, BD-preview-guests, and partner labs.